Insights

Washington – November 5, 2025: Crowell & Moring ranked nationally in 20 practice areas in the 2026 edition of Best Lawyers "Best Law Firms." In addition, the firm was ranked in 38 metropolitan categories. 

Washington – August 20, 2025: The 2026 edition of The Best Lawyers in America® has recognized 44 Crowell & Moring lawyers as "Best Lawyers." 

On October 1, 2026, Judge Brian M. Cogan of the U.S. District Court for the Eastern District of New York denied NYP’s motion to dismiss a consolidated antitrust complaint brought by three self-funded union health plans. The ruling is significant for two reasons. First, it demonstrates that plaintiffs can successfully allege market power against hospital systems even in the absence of traditionally high market shares. Second, the court’s reasoning closely tracks the arguments advanced by the DOJ in its Statement of Interest filed in the case: that market power need not be established through market share alone and can be shown through direct evidence such as supracompetitive pricing, and that exclusionary conduct and rival foreclosure are not required elements of a Section 1 claim. The recent decision validates the government’s legal theories and could enhance the viability of the DOJ’s parallel action against NYP, which is currently proceeding in the Southern District of New York.

California recently enacted two laws instituting new restrictions and requirements for health care transactions. On October 6, Governor Newsom signed SB 351, which codifies elements of the state’s corporate practice of medicine doctrine and strengthens restrictions against private equity, hedge fund, and other private investor control of health care organizations and operations. On October 11, Newsom signed AB 1415, which expands the scope of parties and relevant transactions that require pre-transaction notice to the state’s Office of Health Care Affordability (OHCA). Both laws are intended to provide the State of California greater oversight of transactions involving health care entities, and raise additional hurdles for parties seeking to acquire or sell health care operations in the state,[1] consistent with a broader trend across the country. The key points of each of the California laws are summarized below:

Federal Trade Commission Chair Andrew Ferguson announced on February 24, 2025, that the FTC will create the agency’s “first-ever” labor task force, signaling the agency’s continued focus on competition in labor markets, answering an open question from companies as to the fate of the agency’s no-poach and non-compete enforcement priorities. On February 26 Chair Ferguson followed up on his announcement with a Directive Regarding Labor Markets Task Force, providing additional details on the task force and the agency’s priorities.

Crowell & Moring’s work in Aetna’s $5.7 billion acquisition of Coventry Healthcare featured.

Gain insightful knowledge on key cartel risk and compliance issues. Eminent officials from the European Commission and national competition authorities as well as leading private practitioners and in-house counsel will debate practical challenges to help you develop an effective strategy for your business needs and services.

Please join Crowell & Moring for the second in a series of webinars focused on key issues of importance to the health care industry. This program will focus on the latest developments in health care antitrust affecting providers, payors, and others in the health industry.

The Federal Trade Commission (FTC) recently lifted many guardrails that channeled its rulemaking authority for broad swaths of the U.S. economy. With an expected increase of rulemaking activity, regulation of competition may increasingly shift from ex-post antitrust enforcement to ex-ante regulatory obligations. Intended to intervene before any harm is caused, these obligations suggest a precautionary approach toward market innovations. How should regulators use the FTC rulemaking authority in today’s rapidly changing markets?